Will Life on Mars Require a Genetic Rewrite?
By Scott Solomon,
The MIT Press Reader
| 02. 12. 2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp autumn morning. “Just so I can get there faster. Not because I’m late for a meeting, just because it’s taking too long to walk…I’m the only one I know who runs to work to get there faster."
Mason is a professor of physiology and biophysics at Weill Cornell Medicine. At least that’s his official title. He seems to be working on a hundred different projects all at once, ranging from tracking changes in the virus that causes COVID-19 to helping corals adapt to climate change.
The previous day, I had visited his research group on the Upper East Side. The Mason Lab occupied four separate laboratories across three buildings and was still growing. Although they were pursuing a wide range of projects, a major focus of their work was on how the human genome and microbiome are affected by spaceflight...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...